Lupus Nephritis Treatment Consensus and Future Directions
Reviewers discussed new and conventional therapies for lupus nephritis and the prospect of precision medicine.
Diagnosis & Disease Information
Update on Lupus Nephritis Management
A review of scientific papers highlights recent advances in lupus nephritis management.
CD19-CAR T Cell Therapy Fast Tracked for Systemic Lupus Erythematosus
CABA-201 is a 4-1BB-containing fully human CD19-CAR T cell therapy.
Zetomipzomib Reduces Proteinuria in Proliferative Lupus Nephritis
Kidney function remained stable throughout the 25 week treatment period.
Death Risk Higher in Older Adults Not Followed Up After Lupus Hospitalization
More than a third of lupus hospitalizations lacked follow-up with a primary care physician or rheumatologist.
CKD Progression in Lupus Nephritis Tied to Kidney Cortical Inflammation
According to investigators, the existing NIH definition of interstitial inflammation in the kidneys of patients with lupus nephritis needs to be modified to account for inflammation in areas with and without fibrosis.
Kidney Biopsy Findings Predict Risk of Cardiovascular Events in CKD
Histologic lesions in the kidney may reflect systemic processes that lead to cardiovascular events, according to investigators.
Beta-2 Microglobulin Predicts Lupus Nephritis, SLE Disease Activity
Serum beta-2 microglobulin can be used to monitor kidney damage in systemic lupus erythematosus for earlier diagnosis of lupus nephritis.
Pretransplant Immunosuppression for Glomerulonephritis Ups Malignancy Risk
Patients receiving significant amount of immunosuppression prior to kidney transplantation should be counseled on these malignancy risks, according to investigators.
Childhood-Onset Lupus Nephritis Linked With Adverse Outcomes
Early diagnosis and treatment of childhood-onset systemic lupus erythematosus is important to prevent lupus nephritis outcomes such as end-stage kidney disease.
- Loading...
Loading...
Next post in Lupus Nephritis
Loading... 
Loading...